Back
Pacific Biosciences of California Vs. Anterix Industry Stock Comparison
Sell
32
PACB
Pacific Biosciences of California
Last Price:
1.36
Seasonality Move:
6.7%
Buy
73
ATEX
Anterix
Last Price:
39.58
Seasonality Move:
-3.69%
Sell
32
Pacific Biosciences of California (PACB)
is a Sell
Is Pacific Biosciences of California a Buy, Sell or Hold?
- The current Pacific Biosciences of California [PACB] share price is $1.37. The Score for PACB is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- PACB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
73
Anterix (ATEX)
is a Buy
Is Anterix a Buy, Sell or Hold?
- The current Anterix [ATEX] share price is $39.62. The Score for ATEX is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- ATEX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PACB Stock Price Chart
What is Pacific Biosciences of California's stock price today?
-
The Pacific Biosciences of California share price today is $1.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing slight buying pressure.
PACB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 32.35 | Sell |
| Chaikin Money Flow: | 5138948 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.52 - 1.96) | Sell |
| Bollinger Bands (100): | (1.47 - 4.71) | Sell |
ATEX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.5 | Buy |
| Relative Strength Index (14 RSI): | 78.56 | Buy |
| Chaikin Money Flow: | 432335 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.37 - 34.53) | Buy |
| Bollinger Bands (100): | (31 - 36) | Buy |
PACB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.45 | Sell |
| 20-day SMA: | 1.71 | Sell |
| 50-day SMA: | 1.75 | Sell |
| 200-day SMA: | 5.6 | Sell |
| 8-day EMA: | 1.46 | Sell |
| 20-day EMA: | 1.64 | Sell |
| 50-day EMA: | 2.07 | Sell |
| 200-day EMA: | 5.09 | Sell |
ATEX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.25 | Buy |
| 20-day SMA: | 32.33 | Buy |
| 50-day SMA: | 32.3 | Buy |
| 200-day SMA: | 32.71 | Buy |
| 8-day EMA: | 33.71 | Buy |
| 20-day EMA: | 32.62 | Buy |
| 50-day EMA: | 32.58 | Buy |
| 200-day EMA: | 32.91 | Buy |
Pacific Biosciences of California Earnings Growth & PACB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.18 per share.
Anterix Earnings Growth & ATEX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.71 per share, an increase this year of $3.17 per share, and a decrease next year of $2.65 per share.
Pacific Biosciences of California Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Anterix Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||